JP Morgan Healthcare Conference & Biotech Showcase 2023
We know that groundbreaking biotech innovators require experienced, agile partners who put an emphasis on the needs of today while preparing for the potential of tomorrow.
With over 30 years of experience working closely with biotech companies, including almost every new therapeutic category across all points along the asset development and commercialization continuum, Syenos Health promises transparency and agility with our unique position to address ever-evolving biotech dynamics with relevant, efficient custom solutions.
Be sure to find us in San Francisco at the J.P. Morgan Healthcare Conference and Biotech Showcase events.
Or, schedule a time to meet with our team to discuss your product development challenges.
Biotech Showcase Featured Panels
Headwinds or Not: Moving Forward Despite the Challenging Environment
Monday January 9 | 12-1:30pm PT
Lee Taurman, EVP and Global Head, Syneos One, Syneos Health
Investing for Commercial Success as an Emerging Company
Monday January 9 | 4-5pm PT
Sachin Purwar, Managing Director, Syneos Health Consulting
Dealmaker’s Intentions 2023—Annual Report
Tuesday January 10 | 4-5pm PT
Neel Patel, Executive Managing Director, Syneos Health Consulting
Additional Details
Want to learn more? Explore Insights Hub
or click on the resources below:
2023 Health Trends: Personally, Purposefully Building What’s Next
The Win-Win of End-to-End Outsourcing for Emerging Biotech
Syneos Health Podcast: Full-Service Commercial
Fireside Chat: Product Commercialization in 2022
The New Path to Market for Emerging Biotech
How Clarity Can Be a Differentiator for Biotechs in Uncertain Times
Investing for Launch Success: Finding the Right Balance
